Total Funding
50
29
Total FundingSeed raised
Growth Score
-21 pts
Heat Score
-29 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
180809
NeuImmune is a biopharmaceutical company that develops innovative vaccines and biopharmaceuticals.
- Thomas Fuerst: Scientific Founder and Chairman
- Alexander K. Andrianov: Co-Founder and Scientific Advisory Board
About the Company
NeuImmune is a biopharmaceutical company that develops innovative vaccines and biopharmaceuticals through the precision glycoengineering and delivery of biologics that address important medical and public health needs. The company provides safe and effective prophylactic and therapeutic treatments based on their novel biomanufacturing and delivery
platforms in order to meet these needs.
